Could Interferon Still Play a Role in Metastatic Renal Cell Carcinoma? A Randomized Study of Two Schedules of Sorafenib Plus Interferon-Alpha 2a (RAPSODY)-Reference-Cited by-同舟云学术

Could Interferon Still Play a Role in Metastatic Renal Cell Carcinoma? A Randomized Study of Two Schedules of Sorafenib Plus Interferon-Alpha 2a (RAPSODY)

Published:2013-02 Issue:2 Volume:63 Page:254-261
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Bracarda Sergio,Porta Camillo,Boni Corrado,Santoro Armando,Mucciarini Claudia,Pazzola Antonio,Cortesi Enrico,Gasparro Donatello,Labianca Roberto,Di Costanzo Francesco,Falcone Alfredo,Cinquini Michela,Caserta Claudia,Paglino Chiara,De Angelis Verena

Publisher

Elsevier BV

Subject

Urology

Reference39 articles.

1. Interferon treatment of renal cell carcinoma: current status and future prospects;Krown;Cancer,1987

2. The role of biological response modifiers in metastatic renal cell carcinoma;Muss;Semin Oncol,1988

3. Sorafenib in advanced clear-cell carcinoma;Escudier;N Engl J Med,2007

4. Sunitinib versus interferon alfa in metastatic renal cell carcinoma;Motzer;N Engl J Med,2007

5. Opportunities and obstacles to combination targeted therapy in renal cell cancer;Sosman;Clin Cancer Res,2007

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New frontiers against sorafenib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers;Pharmacological Research;2021-08

2. Targeted therapy for metastatic renal cell carcinoma;Cochrane Database of Systematic Reviews;2020-10-14

3. Soluble forms of the immune check-point receptor PD-1 and its ligand PD-L1 in blood serum of patients with renal cell carcinoma: clinical and pathologic correlations;Cancer Urology;2019-04-09

4. Efficacy of targeted therapy for advanced renal cell carcinoma: A systematic review and meta-analysis of randomized controlled trials;International braz j urol;2018-04

5. MicroRNA‑30a‑5p suppresses tumor cell proliferation of human renal cancer via the MTDH/PTEN/AKT pathway;International Journal of Molecular Medicine;2017-11-17